Rapid Fire Abstracts
Masliza Mahmod, MD, PhD
Medical Lead
Perspectum, United Kingdom
Masliza Mahmod, MD, PhD
Medical Lead
Perspectum, United Kingdom
Charlie Diamond, MSc
Biomarker Scientist
Perspectum Diagnostics Ltd, United Kingdom
Dean McNish-Millar, MD
Consultant
Moorfields Eye Hospital, United Kingdom
Sacha Bull
Consultant Cardiologist
Royal Berkshire Hospital, Reading, United Kingdom
Alessandra Borlotti, MSc
Image Analyst
Perspectum, United Kingdom
Malgorzata Wamil, MD PhD
Research fellow, cardiology registrar
University of Oxford, United Kingdom
Lin Thaha, MD
Consultant
Moorfields Eye Hospital, United Kingdom
Ravi Pattanshetty, MD
Medical Director
Perspectum, United Kingdom
Helena Thomaides-Brears, PhD
Programme Lead for Metabolic and Inflammatory Disease
Perspectum Diagnostics Ltd, United Kingdom
Rajarshi Banerjee, MRCP DPhil
CEO
Perspectum Diagnostics, United Kingdom
Ian Yeung, MD
Consultant
Moorfields Eye Hospital NHS Foundation Trust, United Kingdom
Robin Hamilton, MD
Consultant
Moorfields Eye Hospital NHS Foundation Trust, United Kingdom
DR had significantly reduced indexed LV end-diastolic (71 vs 89 ml/gm2, p< 0.001) & LV stroke volumes (41 vs 53 ml/gm2, p< 0.001), impaired global longitudinal (GLS -15 vs -18 %, p< 0.001) & circumferential strains (GCS -18 vs -20 %, p=0.027), increased myocardial T1 (1210 vs 1176 ms, p=0.016), elevated epicardial adipose tissue (10.5 vs 8.2 cm2, p=0.046), and reduced proximal descending aortic distensibility (0.002 vs 0.005 mmHg-1, p< 0.001), when compared to controls. These differences remained significant after adjustment for confounding factors (age, sex and BMI). Although numerically there were increased LV wall thickness, reduced LVEF and elevated pericardial fat in DR, the differences were not significant compared to controls after correction for confounding factors. Correlation analyses demonstrated that reduced GLS correlated with both increased epicardial and pericardial fat, while reduced GCS correlated with increased pericardial fat in DR. Assessment of the liver and pancreas demonstrated significantly elevated cT1 and srT1 levels, respectively in DR patients when compared to controls. After controlling for age, sex and BMI, liver cT1 was independently associated with both epicardial and pericardial fat, but not LV wall thickness or strain.
Conclusion: When compared to healthy controls, patients with DR have subclinical LV systolic dysfunction (impaired strain) despite preserved LVEF, which correlates with elevated epicardial fat and increased liver fibroinflammation. Our findings suggest that patients with T2DM and retinopathy without history of CVD may have underlying cardiac diseases and therefore should be considered for further cardiac evaluation. Comprehensive multi-organ imaging in DR patients for evaluation of cardiac and other organ health would allow risk and therapeutic stratification in these patients.